Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 2123-2140
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2123
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2123
Figure 8 Effect of serpin family E member 1 overexpression on gastric cancer cell proliferation and the signal-regulated kinase-1/2 pathway invitro and invivo.
A: Expression of signal-regulated kinase-1/2 (ERK1/2) and p-ERK1/2 in SGC7901 co-transfected cells; B: Image of xenograft tumors at day 18 post-inoculation; C: Xenograft tumor growth, volume, and mass at day-18 post-inoculation. n = 5 mice per group; D: Ki67 expression in xenograft tumor tissue; Scale bar = 20 μm; E: E-cadherin, vimentin, serpin family E member 1, ERK1/2, and p-ERK1/2 expression in xenograft tumor tissues. aP < 0.05; bP < 0.01; cP < 0.001. SERPINE1: Serpin family E member 1; ERK1/2: Signal-regulated kinase-1/2.
- Citation: Bai HX, Qiu XM, Xu CH, Guo JQ. MiRNA-145-5p inhibits gastric cancer progression via the serpin family E member 1- extracellular signal-regulated kinase-1/2 axis. World J Gastrointest Oncol 2024; 16(5): 2123-2140
- URL: https://www.wjgnet.com/1948-5204/full/v16/i5/2123.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.2123